U.S. Navy seeks FDA approval for clinical trial of Hemopure

12/11/2008 | MedGadget.com

The U.S. Naval Medical Research Center has submitted to the FDA a revised application to commence a clinical trial of Hemopure -- a stabilized hemoglobin used in the treatment of trauma patients in the battlefield. Hemopure, a product of Mass.-based firm Biopure, would eliminate the need for blood transfusions after surgery by helping patients build up their own reserves of red blood cells.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC